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Introduction. Intravascular lymphoma (IVL) is an uncommon and oen fatal disease characterized by intraluminal proliferation of 
lymphomatous cells within blood vessels. Because of a heterogeneous clinical presentation and lack of sensitive diagnostic protocols, 
diagnosis of IVL is most oen made at autopsy. However, with early diagnosis and appropriate chemotherapy, the prognosis is 
greatly improved and complete remission is possible. In order to broaden the possible presentations of IVL, we present a patient 
with an atypical manifestation of biopsy-proven intravascular large B-cell lymphoma who suffered dissections of both intracranial 
and extracranial arteries in addition to progressive intracranial hemorrhages. Case Report. A 47-year-old woman presented with 
unilateral paresthesias. She developed progressive multifocal infarcts and hemorrhage with dissections of both intracranial and 
extracranial arteries, resulting in coma. Brain biopsy revealed IVL. She received aggressive chemotherapy and remains in complete 
remission with good neurologic recovery. Conclusion. IVL is known to exert its pathology on small arteries and capillaries, but is 
not known to cause dissections of large vessels. e diagnosis should be considered in cases with unexplained arterial dissections 
and progressive strokes. Early diagnosis with appropriate laboratory screening and tissue confirmation by biopsy can lead to greatly 
improved outcomes.
1. Introduction
Intravascular lymphoma (IVL) is recognized by the World 
Health Organization (WHO) as an extremely rare subtype of 
diffuse extranodal large B-cell non-Hodgkin’s lymphoma with 
an estimated annual incidence of 0.5 cases per 1,000,000 [1]. 
IVL leads to intraluminal proliferation of neoplastic lymphoid 
cells in small and medium vessels [2]. ese cells have lost the 
ability for transvascular migration due to defects in adhesion 
molecules [3]. IVL can involve any organ system, particularly 
the central nervous system (CNS), and its protean neurological 
manifestations oen hinder diagnosis. Patients can present 
with subacute encephalopathy or dementia, paralysis, seizures, 
or multifocal cerebrovascular events, by order of frequency 
[1, 4, 5]. Systemic symptoms vary, but fever and skin lesions 
are the most common, whereas lymphadenopathy is usually 
absent [2].
Serologic abnormalities include anemia (63%), high lac-
tate dehydrogenase (LDH) (82%) and beta 2-microglobulin 
levels (86%) [6]. Bone marrow involvement occurs in 32% of 
patients, and cerebrospinal fluid (CSF) rarely contains malig-
nant cells [6]. Magnetic resonance imaging (MRI) is nonspe-
cific and can be normal, though there are numerous reports 
of rapid progression of cerebral infarcts [5]. Organ biopsy is 
the gold standard for diagnosis of IVL but is frequently per-
formed too late, and cases with CNS involvement are most 
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oen diagnosed post-mortem (60%) [7]. Random skin biop-
sies may help make the diagnosis earlier, with up to 83% sen-
sitivity even without skin findings on exam [8, 9]. While IVL 
can have a grim prognosis with average untreated survival 
only a few months from diagnosis, chemotherapies containing 
rituxumab and doxorubicin have improved three-year survival 
rates to 60%, which may be further increased when metho-
trexate is added [1, 10].  When diagnosed and treated promptly, 
complete remission is seen in up to 42% of cases, although 
recent survival data with adequate treatment are lacking [11]. 
We describe an unusual presentation of IVL with multiple 
dissections of both intracranial and extracranial blood vessels 
and progressive intracranial hemorrhages (ICH).
2. Case Report
A 47-year-old woman with a history of delayed gastric emp-
tying presented with migratory paresthesias traveling up her 
right side. ese episodes occurred daily, lasted 20 minutes, 
and were associated with headache and confusion. During the 
month preceding her admission, she was admitted to an out-
side hospital with right-sided paresthesias, worsening 
migraines with visual aura, and somnolence. Initial con-
trast-enhanced MRI of the brain did not have acute findings, 
and showed minimal background nonspecific T2-weighted-
fluid-attenuated inversion recovery (FLAIR) hyperintensities 
in the subcortical white matter.
Aer concern of a focal motor seizure, the patient was 
transferred to our hospital. She had no lymphadenopathy, skin 
lesions, or edema. Neurologically, she was initially somnolent 
but easily arousable, and once alert remained interactive and 
oriented sufficient to participate in the Montreal cognitive 
assessment (MOCA). Her MOCA score was 22/30 with nota-
ble deficits in attention, language and abstraction – a marked 
departure from her high-functioning baseline. e remainder 
of her neurologic exam was unremarkable. Laboratory evalu-
ation including cerebrospinal fluid analysis was unrevealing 
(Table 1).
MRI of the brain was repeated 13 days aer the initial scan 
(Figure 1(a)), showing two new foci of restricted diffusivity in 
the le centrum semiovale consistent with interval infarcts. 
ere was also progression of FLAIR hyperintensities in the 
right anterior cingulate gyrus and inferior right and posterior 
le frontal lobes, with corresponding areas of petechial 
Figure 1: (a) Le to right: computed tomography (CT), fluid-attenuated inversion recovery (FLAIR), T1 post-contrast, and susceptibility-
weighted imaging (SWI) 13 days aer admission showed minimal findings on CT, but FLAIR hyperintensities and petechial hemorrhages on T1 
and SWI images (arrows). ese had progressed compared to initial imaging (not shown). (b) Le to right: Carotid and cerebral angiography 
showing irregular corrugated and beaded appearance of the cervical carotid arteries and subtle intracranial vessel narrowing (arrows), and 
two new foci of restricted diffusivity on diffusion weighted imaging (DWI) in the bilateral centrum semiovale consistent with interval infarcts 
(arrows). Note: there was another infarct in the le centrum semiovale on an adjacent slice not shown above.
(a)
(b)
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hemorrhage on T2*-weighted imaging. Continuous electro-
encephalograms (EEG) confirmed encephalopathic slowing 
without epileptiform discharges. Cerebral angiography showed 
irregular corrugated and beaded appearance of the cervical 
carotid arteries, thought to be consistent with chronic fibro-
muscular dysplasia (Figure 1(b)). High-resolution vessel wall 
MRI did not show arterial wall enhancement to suggest vas-
culitis. 18F-fluorodeoxyglucose positron emission tomogra-
phy (FDG-PET) scan of the brain (Figure 2) and computed 
tomography (CT) of the chest, abdomen, and pelvis were 
unrevealing.
As an extensive workup was thus far negative (CSF OCB, 
flow, cytology, HSV/VZV, ANA, ANCA, Mayo paraneoplastic 
panel, VGKC, AQ4, NMDA, tox screen, EEG without obvious 
seizure), the patient received a presumptive diagnosis of idi-
opathic encephalitis and was treated empirically with a five-
day trial of intravenous methylprednisolone followed by a 
prednisone taper. She improved clinically for one month aer 
discharge and returned to work, but gradually developed wors-
ening headache, vomiting, lethargy, and episodic le facial 
droop. Repeat MRI (Figure 3(a)) showed marked interval 
progression with new areas of cytotoxic edema/infarction, 
vasogenic edema, and a moderate-sized right temporoparietal 
hemorrhage causing cerebral edema and midline shi, with 
additional petechial hemorrhages on T2*-weighted imaging. 
ere was extensive new sulcal FLAIR signal and enhance-
ment compatible with blood-brain barrier breakdown.
CSF analysis demonstrated marked protein elevation 
(140 mg/dL) without pleocytosis. Repeat catheter angiography 
showed a new right cervical internal carotid artery dissection 
in the distal extracranial portion as well as progression of lumi-
nal irregularities indicative of progressive vasculopathy 
(Figure 3(b)). Magnetic resonance angiography (MRA) of the 
head and neck the same day revealed additional bilateral ver-
tebral artery dissections involving the entire right vertebral 
artery and the le V3/4 segments, as well as new narrowing of 
the bilateral temporal arteries. ere was no instrumentation 
above the level of the common carotid arteries or vertebral 
artery origins during the initial catheter angiogram to explain 
this finding. Our differential diagnosis expanded to include 
atypical vasculitides, inflammatory amyloid angiopathy, com-
plicated Posterior reversible encephalopathy syndrome (PRES), 
and reversible cerebral vasoconstriction syndrome (RCVS), or 
IVL (Table 2). Because an elevated LDH level in an atypical 
case without infection can be suggestive of IVL, we measured 
LDH and found hers to be elevated to 450 U/L (Table 1).
e patient’s clinical course progressed to coma due to 
cerebral edema and hematoma expansion. A right temporo-
parietal brain biopsy was obtained. Sections stained with 
hematoxylin-and-eosin showed small cortical vessels patho-
logically distended with neoplastic lymphocytes. ese cells 
were pleomorphic, hyperchromatic, and displayed prominent 
nucleoli and occasional mitoses (Figure 4(a)). ey did not 
spill out into the surrounding neuropil. Immunohistochemistry 
revealed these malignant cells to be diffusely positive for 
CD20, a B-cell marker (Figure 4(b)). e tumor cells also 
 labeled widely for Mindbomb E3 Ubiquitin Protein Ligase 1 
(MIB-1), a marker of proliferation. Based on these findings, 
the patient was diagnosed with IVL. e patient was urgently 
Table 1: Additional laboratory findings.
aLDH was analyzed 45 days aer initial test results. bFerritin was analyzed 20 








Creatinine 1.24 mg/dL *High
Glucose 103 mg/dL
Calcium 9.2 mg/dL
Protein, total 6.1 g/dL *Low
Albumin 4.1 g/dL
Bilirubin 0.7 mg/dL
Alkaline phosphatase 60 U/L
AST 17 U/L
ALT 11 U/L










Platelet 152 k/µl *Low
MPV 6.9 fL
Granulocyte %, # 63.4, 2.4 k/µl
Monocyte %, # 9.1, 0.3 k/µl %*High
Eosinophil %, # 3.1, 0.1 k/µl
Basophil %, # 0.4, 0.0 k/µl
Lymphocyte %, # 24, 0.9 k/µl
Paraneoplastic autoantibody evaluation (CSF)
Neuronal nuclear Ab, Type 1 Negative
Neuronal nuclear Ab, Type 2 Negative
Neuronal nuclear Ab, Type 3 Negative
Glial Nuclear Ab Negative
Purkinje cell cytoplasmic Ab, 
Type 1 Negative
Purkinje cell cytoplasmic Ab, 
Type 2 Negative





LDHa 427 U/L *High
Ferritinb 1,107 ng/mL *High
TSH 1.83 mU/L
CRP 0.1 mg/dL
Prothrombin time 13.7 sec
INR 1.1
Sed rate, Westergren 2 mm/hr
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started on chemotherapy with rituximab, cyclophosphamide, 
doxorubicin, vincristine, and prednisone (R-CHOP) along 
with decompressive craniectomy, which led to reversal of coma 
and liberation from the ventilator several days later. She then 
received methotrexate, which halted progression of her disease 
and allowed her to return home with a modified Rankin Scale 
of 1. e patient remains in remission today, four years later.
3. Discussion
IVL involving the CNS is an aggressive condition with a poor 
prognosis because its protean clinical manifestations fre-
quently preclude diagnosis. Laboratory and imaging tools 
provide clues to the etiology, but lack adequate sensitivity and 
specificity. Our patient exhibited an unusual presentation of 
multiple arterial dissections and progressive ICH. She under-
went an extensive workup for progressive encephalopathy 
until her decline into coma necessitated a brain biopsy. e 
pathological proliferation of intraluminal lymphocytes in the 
small intracranial vessels explains our patient’s symptoms and 
imaging findings. As arterioles, venules, and capillaries stag-
nate with malignant cells, intraparenchymal hemorrhage and 
infarction can occur. However, the formation of multiple 
large-artery dissections in her clinical course remains unex-
plained. Microvessels are a known source of intramural hemat-
omas in the setting of arterial dissection and intraplaque 
hemorrhage, attributed to vasa vasorum leakage or rupture 
within the wall of carotid and vertebral arteries [12]. It is 
unclear whether IVL is capable of infiltrating these small ves-
sels (vasa vasorum) within the arterial wall to cause rupture 
and dissection of the intima and adventitia of the artery.
Given the limitations of an individual reported case, we 
cannot rule out an alternative etiology for her dissections. It 
is possible that she had either underlying fibromuscular dys-
plasia (FMD) or another condition explaining her dissections, 
in addition to IVL explaining her brain findings. However, her 
angiographic studies showed interval development of new 
Figure 2: (a) Le to right: Repeat CT, FLAIR, T1post, and SWI showing marked interval progression of hemorrhages on CT and SWI with 
surrounding edema on FLAIR and subtle foci of enhancement on T1 post-contrast images (arrows). e vasogenic edema and moderate-
sized right temporoparietal hemorrhage caused cerebral edema and midline shi, and there were multiple additional petechial hemorrhages. 
ere was also new sulcal FLAIR signal with subtle enhancement consistent with blood-brain barrier breakdown. (b) Le to right: Repeat 
catheter angiography showed a new right cervical internal carotid artery dissection on carotid angiography (arrow), progression of luminal 
irregularities in the distal the middle cerebral artery and the anterior cerebral artery branches (arrows), and new areas of cytotoxic edema/
infarction on DWI (arrows).
(a)
(b)
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(a)
(b)
Figure 3: (a) FDG-PET scan of the brain demonstrated mildly diminished FDG uptake in the le more than right bilateral temporal, frontal, 
and parietal lobes as well as the in the posterior cingulate, precuneus and the primary visual and visual association cortices. e most prominent 
metabolic reduction was in the le frontal association cortex. ere were no focal areas of hypermetabolism in the mesial temporal lobes or 
elsewhere. is diffuse pattern of mild metabolic changes was not specific for any inflammatory disease or other process, and most suggestive 
of a global encephalopathy with asymmetry due to more pronounced deficits in the le hemisphere. (b) PET scan of the body was notable 
for bilateral pleural effusions as well as pericardial effusion and scattered nonspecific ill-defined hypermetabolic pulmonary nodules with 
differential including infectious/inflammatory process or pulmonary lymphoma with max SUV (standard uptake value) of 6.8.
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diagnostic results that have the potential to critically delay the 
initiation of therapy. Imaging findings such as diffuse scattered 
foci of T2 hyperintensities and diffusion restriction, petechial 
and parenchymal hemorrhages, with or without arterial dis-
sections should raise the suspicion for this elusive disease even 
in the absence of detectable mass lesions. Early clinical diag-
nostic strategies may enable treatment sooner. ese strategies 
make the diagnosis by assimilating other important data 
including serum tumor markers, LDH (lactate dehydroge-
nase) and soluble IL2R (interleukin-2 receptor), as well as 
random skin and bone marrow biopsy with flow cytometry 
[6, 8, 9,13, 14]. In particular, CNS involvement of lymphoma 
at diagnosis portends a worse prognosis and these patients 
are thought to have a higher rate of relapse, especially in the 
CNS [15]. It has been proposed that positive findings on skin 
biopsy may be useful in cases without proven CNS disease as 
a risk factor for later relapse in the CNS, though further inves-
tigation is needed to prove this [15]. ere remains a need for 
large-artery dissections associated with clinical and radio-
graphic progression of her IVL. To date, there have been no 
reports in the literature to support IVL involving large arteries 
such as carotid and vertebral arteries, a disease known to 
involve mainly arterioles, venules, and capillaries.
is case highlights the need for a high index of suspicion 
for an underlying IVL in the setting of multiple intracranial 
and extracranial dissections and ICH, and progression of find-
ings despite standard medical therapy. Our patient recovered 
from her coma and currently remains in remission four years 
later owing to accurate histopathological diagnosis and 
prompt treatment, which stands in stark contrast to the major-
ity of patients who are diagnosed postmortem. In evaluating 
progressive encephalitis of unclear etiology, prompt brain 
biopsy proved essential in directing treatment. However, there 
may be reasons when brain biopsy may be delayed or inaccu-
rate due to concerns regarding procedural risk or when there 
is little to no tumor mass formation, which could lead to non- 
Figure 4: (a) Hematoxylin-and-eosin of the brain biopsy showed small cortical vessels pathologically distended with neoplastic lymphocytes 





Cerebral sinus thrombosis Catheter angiogram
Vasculitis ANA, ANCA, SSA, SSB, ESR, CRP, Hepatitis panel
Reversible cerebral vasoconstriction syndrome Catheter angiogram and high resolution vessel wall MRI
Autoimmune and paraneoplastic encephalitis VGKC, NMDA, CASPR2, LGI1 paraneoplastic antibody panel, Cerebral FDG PET scan
CNS malignancy or metastasis CSF cytology and flow cytometry, CT of the chest, abdomen, pel-vis. PET of the brain
Infectious endocarditis with septic emboli ESR, CRP, lactate
Encephalitis (Infectious etiologies) TB, RPR, HIV, VZV, HSV, EBV, WNV, HTLV1/2, and others
Cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL) MRI
Drug-induced vasculopathy Urine drug screen
Amyloid angiitis Congo red and thioflavin on biopsy, MRI with  Susceptibility-weighted imaging
Progressive multifocal leukoencephalopathy HIV antibodies
7Case Reports in Neurological Medicine
 [9]  N. Asada, J. Odawara, S.-I. Kimura et al., “Use of random skin 
biopsy for diagnosis of intravascular large B-Cell lymphoma,” 
Mayo Clinic Proceedings, vol. 82, no. 12, pp. 1525–1527, 2007.
[10]  Y. Sekiguchi, A. Shimada, H. Imai et al., “Intravascular large 
B-cell lymphoma with pontine involvement successfully treated 
with R-CHOP therapy and intrathecal administration: a case 
report and review of literature,” International Journal of Clinical 
and Experimental Pathology, vol. 7, no. 6, pp. 3363–3369, 2014.
[11]  J. A. DiGiuseppe, W. G. Nelson, E. J. Seier, J. K. Boitnott, and 
R. B. Mann, “Intravascular lymphomatosis: a clinicopathologic 
study of 10 cases and assessment of response to chemotherapy,” 
Journal of Clinical Oncology, vol. 12, no. 12, pp. 2573–2579, 1994.
[12]  R. R. Patel, R. Adam, C. Maldjian, C. M. Lincoln, A. Yuen, and 
A. Arneja, “Cervical carotid artery dissection: current review 
of diagnosis and treatment,” Cardiology in Review, vol. 20, no. 
3, pp. 145–152, 2012.
[13]  M. Kitayama, M. Ueno, T. Itakura, and T. Yamashita, “Activated 
microglia inhibit axonal growth through RGMa,” PLoS One, vol. 
6, no. 9, Article ID e25234, 2011.
[14]  Y. Masaki, L. Dong, A. Nakajima et al., “Intravascular large B cell 
lymphoma: proposed strategy for early diagnosis and treatment 
of patients with rapid deteriorating condition,” International 
Journal of Hematology, vol. 89, no. 5, pp. 600–610, 2009.
[15]  K. Shimada, T. Murase, K. Matsue et al., “IVL Study Group 
in Japan. Central nervous system involvement in intravascular 
large B-cell lymphoma: A retrospective analysis of 109 patients,” 
Cancer Science, vol. 101, no. 6, pp. 1480–1486, 2010.
better pathophysiologic understanding of this elusive 
disease.
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